Results

Total Results: 3,024 records

Showing results for "diseases".

301. Is there an easier way to test for Celiac disease? | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/is-there-an-easier-way-to-test-for-celiac-disease
     March 11, 2012 - Is there an easier way to test for Celiac disease? … (For example, an ethnic group, stage or severity of a disease.) … Help understand the disease better and a possible cure or treatment Describe the timeframe in which … role or perspective: (you may select more than one category if appropriate) Help understand the disease … Please tell us how you heard about the Effective Health Care Program Diagnosis of Celiac Disease

302. What are the comparative diagnostic accuracy, diagnostic thinking, therapeutic, and patient outcome efficacy of non-invasive tests for the risk stratification of patients with coronary artery disease? | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/what-are-the-comparative-diagnostic-accuracy-diagnostic-thinking-therapeutic-and-patient-outcome-efficacy-of-non-invasive-tests-for-the-risk-stratification-of-patients-with-coronary-artery-disease
     February 27, 2012 - outcome efficacy of non-invasive tests for the risk stratification of patients with coronary artery disease … Patients with symptomatic and asymptomatic coronary artery disease Are there subgroups of patients … (For example, an ethnic group, stage or severity of a disease.) … (check all that apply) EHC Priority Conditions (updated in 2008) Cardiovascular disease, including … available to aid in the evaluation of patients at intermediate risk of patients with coronary artery disease

303. Procalcitonin for Diagnosis and Management of Sepsis | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/procalcitonin/research-protocol
     April 26, 2011 - Abbreviations: AECOPD = acute exacerbation of chronic obstructive pulmonary disease. … past 5 years: ICAAC (Interscience Conference on Antimicrobial Agents and Chemotherapy), Infectious Diseases … Society, European Society of Clinical Microbiology and Infectious Diseases, International Society for … Infectious Diseases, European Society of Clinical Microbiology and Infectious Diseases, British Infection … Association , Australasian Society for Infectious Diseases, International Sepsis Forum, European Society

304. Disposition of Comments: Technical Brief 34, Impact of Community Health Worker Certification on Workforce and Service Delivery for Asthma and Other Selected Chronic Diseases (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/technical-brief-34-health-worker-certification-comments.pdf
     March 27, 2020 - Health Worker Certification on Workforce and Service Delivery for Asthma and Other Selected Chronic Diseases … Health Worker Certification on Workforce and Service Delivery for Asthma and Other Selected Chronic Diseases … Health Worker Certification on Workforce and Service Delivery for Asthma and Other Selected Chronic Diseases … conducted to test the impact of certification on CHW service delivery, and on patient outcomes in key disease-specific

305. Attention Deficit Hyperactivity Disorder Medications and Risk of Serious Cardiovascular Disease in Children and Youth (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-heart-disease-adults_research.pdf
     November 01, 2011 - respiratory illnesses, seizure and other neurologic disorders, unintentional injuries, cardiovascular diseases … , and other diseases. … §Other serious health conditions included pneumonia, thyroid disease, and kidney disease. … failure Renal dialysis (except single inpatient episode) Respiratory failure Other potentially lethal diseases … of childhood (metabolic diseases, aplastic anemia, congenital immune deficiencies, lethal chromosomal

306. Topic Suggestion Description | Effective Health Care Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/evidence-based-treatment-for-pressure-ulcers-by-stage
     September 22, 2010 - (For example, an ethnic group, stage or severity of a disease.) … Conditions (updated in 2008) Diabetes mellitus Functional limitations and disability Infectious diseases

307. Data Points #4: Trends in the utilization of erythropoiesis-stimulating agents among Medicare beneficiaries with kidney disease | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/erythropoiesis-stimulating-agents-utilization/research
     March 31, 2011 - Trends in the utilization of erythropoiesis-stimulating agents among Medicare beneficiaries with kidney disease … Chronic renal disease affects more than 26 million Americans and is the cause of significant morbidity … Anemia, a common complication, conveys significant risk for cardiovascular disease, faster progression … In fact, most patients with chronic renal disease become anemic. … Points brief was to examine practice trends in the use of ESAs among Medicare beneficiaries with kidney disease

308. Decisional Dilemmas in Discontinuing Prolonged Disease-Modifying Treatment for Multiple Sclerosis | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/multiple-sclerosis
     December 17, 2013 - Decisional Dilemmas in Discontinuing Prolonged Disease-Modifying Treatment for Multiple Sclerosis … December 17, 2013 Research Protocol Archived Discontinuation of Disease-Modifying … Systematic Review Archived Decisional Dilemmas in Discontinuing Prolonged Disease-Modifying

309. Effects of Dietary Sodium and Potassium Intake on Chronic Disease Outcomes and Related Risk Factors | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/sodium-potassium
     March 01, 2017 - Effects of Dietary Sodium and Potassium Intake on Chronic Disease Outcomes and Related Risk Factors … Research Protocol Effects of Dietary Sodium and Potassium Intake on Chronic Disease … 21, 2018 Systematic Review Sodium and Potassium Intake: Effects on Chronic Disease

310. Disease-Modifying Antirheumatic Drugs (DMARDs) in Children With Juvenile Idiopathic Arthritis (JIA) | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/juvenile-arthritis-dmards
     March 09, 2010 - Disease-Modifying Antirheumatic Drugs (DMARDs) in Children With Juvenile Idiopathic Arthritis (JIA) … March 09, 2010 Research Protocol Archived The Effectiveness of Disease-Modifying … Idiopathic Arthritis (JIA) September 26, 2011 Systematic Review Archived Disease-Modifying

311. Cervical Degenerative Disease | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/cervical-degenerative-disease/draft-comments

312. The Effectiveness of Disease-Modifying Antirheumatic Drugs (DMARDS) in Children With Juvenile Idiopathic Arthritis (JIA) | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/juvenile-arthritis-dmards/research-protocol
     March 09, 2010 - Polyarthritis: affects five or more joints during the first 6 months of disease; is subclassified as … with more destructive joint disease. … Evaluating changes in JIA disease status can be challenging. … First, these measures evaluate relative and not absolute changes in disease progression. … Effects of Omega-3 Fatty Acids on Cardiovascular Disease .

313. Attention Deficit Hyperactivity Disorder Medications and Risk of Serious Cardiovascular Disease in Children and Youth | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/adhd-heart-disease-adults/research
     November 01, 2011 - Attention Deficit Hyperactivity Disorder Medications and Risk of Serious Cardiovascular Disease in Children … hyperactivity disorder (ADHD) medication use might be associated with increased risk of serious cardiovascular disease … To examine the association between use of ADHD medications and the risk for serious cardiovascular disease … The primary outcome was serious cardiovascular disease (sudden cardiac death, acute myocardial infarction

314. Comparative Effectiveness Research to Improve Anemia Management and Cardiovascular Disease Outcomes in End-Stage Renal Disease (ESRD) | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/renal-disease-anemia/abstract
     March 31, 2011 - Comparative Effectiveness Research to Improve Anemia Management and Cardiovascular Disease Outcomes in … End-Stage Renal Disease (ESRD) Abstract Archived March 31, 2011 Topic Abstract Background … Expected Date of Completion : June 2013 EHC Priority Condition : End-Stage Renal Disease (ESRD) and … Cardiovascular Disease

315. Rapid Evidence Product_Nonemergent Percutaneous Coronary Intervention Versus Optimal Medical Treatment for Stable Ischemic Heart Disease: A Rapid Response Literature Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/rapid-evidence-heart-disease.pdf
     October 01, 2022 - Background 2 (LVEF), disease in multiple coronary vessels, and/or disease in the proximal portion … Optimal treatment strategies for coronary artery disease in patients with advanced kidney disease: … Management of Coronary Disease in Patients with Advanced Kidney Disease. N Engl J Med. … "[Mesh] OR "coronary artery disease"[tiab] OR "coronary heart disease"[tiab] Guideline, Meta- Analysis … '/exp OR 'coronary artery disease':ti,ab OR 'coronary heart disease':ti,ab 584588 2 debulking:ti

316. Comparative Effectiveness of Noninvasive Technologies for the Diagnosis of Coronary Artery Disease (CAD) in Women | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/cad-women-diagnosis/research-protocol
     December 08, 2010 - cause of mortality for women in the United States. 1 Coronary heart disease—which includes coronary … Current diagnostic concepts to detect coronary artery disease in women. … Non-invasive imaging for coronary artery disease . Technology Assessment. … [mesh] OR "coronary artery disease"[tiab] OR coronary disease[mesh] OR "coronary disease"[tiab] OR "coronary … heart disease"[tiab]) + Comparisons: 6 groups of terms.

317. Pharmacological Management of Crohn's Disease: Future Research Needs | Effective Health Care Program
     effectivehealthcare.ahrq.gov/products/crohns-disease-future
     April 02, 2014 - Pharmacological Management of Crohn's Disease: Future Research Needs Timeline February … 02, 2014 Systematic Review Archived Pharmacological Management of Crohn's Disease

318. Disposition of Comments for Treatment Strategies for Patients With Peripheral Artery Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/peripheral-artery-disease-treatment_disposition-comments.pdf
     May 29, 2013 - Disposition of Comments for Treatment Strategies for Patients With Peripheral Artery Disease … Comments Report Research Review Title: Treatment Strategies for Patients With Peripheral Artery Disease … Treatment Strategies for Patients With Peripheral Artery Disease. … The gaps and disease specific limitation section was particularly nice. … Dietary cholesterol and egg yolks: Not for patients at risk of vascular disease.

319. Comparative Effectiveness of Intravenous Iron Formulations in the Treatment of Anemia in End Stage Renal Disease | Effective Health Care Program
     effectivehealthcare.ahrq.gov/products/renal-disease-iron
     January 24, 2012 - Comparative Effectiveness of Intravenous Iron Formulations in the Treatment of Anemia in End Stage Renal Disease … Comparative Effectiveness of Intravenous Iron Formulations in the Treatment of Anemia in End Stage Renal Disease

320. Quantitative Synthesis: Chapter 1. Decision To Combine Trials (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-chapter-1.pdf
     July 01, 2019 - American Journal of Kidney Diseases. 2016 2016;69(2):172-4. … American Journal of Kidney Diseases. 2016 2016;69(2):172-4. 6. Bowater RJ, Escarela G.